4.0
22. Mai 2026
Ehemaliger Mitarbeiter
London, England
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Fast-learning experience and exposure to different disease indications (multi-project staffing)
Kontras
The firm's narrow focus on competitive intelligence, with no strategy